Next Article in Journal
Improvement of Resistance Change Memory Characteristics in Ferroelectric and Antiferroelectric (like) Parallel Structures
Next Article in Special Issue
Doping of Transparent Electrode Based on Oriented Networks of Nickel in Poly(3,4-Ethylenedioxythiophene) Polystyrene Sulfonate Matrix with P-Toluenesulfonic Acid
Previous Article in Journal
Primary Amine Functionalized Carbon Dots for Dead and Alive Bacterial Imaging
Previous Article in Special Issue
A Highly Selective and Sensitive Fluorescent Sensor Based on Molecularly Imprinted Polymer-Functionalized Mn-Doped ZnS Quantum Dots for Detection of Roxarsone in Feeds
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nanomaterials
Volume 13
Issue 3
10.3390/nano13030438
nanomaterials-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection

by
Rustem Zairov
1,2,*,
Alexey Dovzhenko
1,2,
Natalia Terekhova
1,
Timur Kornev
1,
Ying Zhou
3,
Zeai Huang
3,
Dmitry Tatarinov
1,2,
Guliya Nizameeva
4,
Robert R. Fayzullin
1,
Aidar T. Gubaidullin
1,
Taliya Salikhova
5,
Francesco Enrichi
6,7,
Vladimir F. Mironov
1 and
Asiya Mustafina
1
1
Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences, 8 Arbuzov Str., 420088 Kazan, Russia
2
Institute of Chemistry, Kazan Federal University, Kremlevskaya Str. 18, 420008 Kazan, Russia
3
Institute of Carbon Neutrality, School of New 401 Energy and Materials, Southwest Petroleum University, Chengdu 610500, China
4
Department of Nanomaterials and Nanotechnology, Kazan National Research Technological University, 68, Karl Marx Str., 420015 Kazan, Russia
5
Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, 18 Kremlevskaya Str., 420008 Kazan, Russia
6
Department of Computer Science, University of Verona, Strada Le Grazie 15, 37134 Verona, Italy
7
CNR-ISP, Institute of Polar Science of the National Research Council, Via Torino 155, 30174 Venezia, Italy
*
Author to whom correspondence should be addressed.
Nanomaterials 2023, 13(3), 438; https://doi.org/10.3390/nano13030438
Submission received: 5 December 2022 / Revised: 12 January 2023 / Accepted: 19 January 2023 / Published: 21 January 2023
(This article belongs to the Special Issue Recent Advances in Luminescent Nanocomposites for Sensing Applications)
Browse Figures
Review Reports Versions Notes

Abstract

:
The present work demonstrates the optimization of the ligand structure in the series of bis(phosphine oxide) and β-ketophosphine oxide representatives for efficient coordination of Tb3+ and Eu3+ ions with the formation of the complexes exhibiting high Tb3+- and Eu3+-centered luminescence. The analysis of the stoichiometry and structure of the lanthanide complexes obtained using the XRD method reveals the great impact of the bridging group nature between two phosphine oxide moieties on the coordination mode of the ligands with Tb3+ and Eu3+ ions. The bridging imido-group facilitates the deprotonation of the imido- bis(phosphine oxide) ligand followed by the formation of tris-complexes. The spectral and PXRD analysis of the separated colloids indicates that the high stability of the tris-complexes provides their safe conversion into polystyrenesulfonate-stabilized colloids using the solvent exchange method. The red Eu3+-centered luminescence of the tris-complex exhibits the same specificity in the solutions and the colloids. The pronounced luminescent response on the antibiotic ceftriaxone allows for sensing the latter in aqueous solutions with an LOD value equal to 0.974 μM.

1. Introduction

Luminescent lanthanide complexes have long been attracting researchers due to their excellent optical properties. They are widely used as building blocks for luminescent nanomaterials for application in biomedical analysis, medical diagnosis, and cell imaging [1,2,3]. Long luminescence lifetimes, sharp characteristic emission bands, and large Stoke’s shifts allow the removal of biological background autofluorescence, which is of great importance when biomedical experiments are conducted.
However, due to the difficulties with direct sensitization of Ln(III), luminescence organic ligands (Ls) are usually used to excite lanthanides indirectly mainly with ligands’ triplet level [4,5,6,7]. Within the complex of Ln(III)–L, the efficiency of ligand-to-metal energy transfer governs the resulting brightness and, hence, luminescence performance in various applications. It is worth noting that β-diketones demonstrated outstanding chelating properties towards all lanthanide series forming stable six-membered chelate rings [8,9,10]. The structural variability of beta-diketones gave rise to a number of Ln(III) complexes with record optical properties due to the precise tuning of triplet energy level with a simple change of substituents [11,12,13]. Moreover, a great number of such complexes were successfully converted into aqueous colloids using the solvent exchange technique [8,14]. However, 1,3-diketonates are quite selective in sensitizing specific lanthanide ions. In this regard, the design of new ligands that can excite different metals of the lanthanide series and nanomaterials exhibiting both diverse lanthanide-centered luminescence in the visible region of the spectrum, e.g., green or red, and good colloid properties simultaneously is a top challenge in current chemistry.
Phosphine oxides attracted great attention as promising extractants for 4(5)f-metal ions [15,16,17,18,19,20]. The chemistry of 1,3-bis-phosphine oxides is rapidly developing, which is mainly because bis(phosphine oxides) are efficient ligands allowing diverse complexation with lanthanide and calcium ions [21,22,23,24,25,26]. The great impact of the structure of the group linking two phosphine oxides on the complexation mode is worth noting. In particular, the chelation of lanthanide ions by imido-bis(phosphine oxides) is followed by a deprotonation [27,28,29], while bis(phosphine oxides) bridged via methylene group tend to form stable complexes with lanthanide ions without deprotonation [30,31]. A similar chelating ability towards lanthanide ions was previously demonstrated for carbamoylphosphine oxide derivatives [32,33,34]. Having a valence of five, the phosphorus atom brings an additional option for introducing P-substituent compared to dicarbonyles. This makes carbamoylphosphine oxides (CMPOs) and bis(phosphine oxides) beneficial in terms of structural variations and possible functional add-ons. Aryl-substituted phosphorus-containing ligands have recently been documented to grant substantial antenna-effect sensitizing luminescence of Rare Earth Elements (REEs), which are in demand in luminescence-related applications [35,36]. However, to the best of our knowledge, the applicability of such complexes in the development of nanosensors is very poorly documented in the literature, if at all.
The wide applicability of lanthanide complexes in the fluorescent sensing of residual amounts of drugs, including antibiotics, in water or biological fluids is well known [37,38,39,40,41,42,43]. In this regard, the synthesis of new lanthanide complexes, where ligand-to-metal energy transfer is enough for sensitizing lanthanide-centered luminescence, and where ligand-metal coordination bonds are tight enough for the safe conversion of the complexes into water-dispersible nanomaterial with high lanthanide-centered luminescence, is a challenging scientific task.
Thus, the present work represents the already known [29,30] (Figure 1a,b) and newly synthesized (Figure 1c,d) ligands for Tb3+ and Eu3+ ions. An additional methoxyphenyl fragment was purposely introduced at the alpha-position to promote further build-ups, to control the lanthanide coordination center symmetry for additional boosting lanthanide-centered luminescence, and for additional hydrophobic shielding of the inner-sphere of the lanthanide ions minimizing solvent-induced nonradiative relaxation. The synthesis of the complexes and their structural and spectral characterization in the solid state and solutions are described in detail in this work. The efficiency of converting the as-synthesized complexes into the aqueous PSS-stabilized colloids is correlated with the structures of the complexes and the ligands. The diverse physico-chemical techniques applied for the characterization of the ligands, complexes, and nanoparticles on molecular, supramolecular, and nano-levels are focused on the ability of the ligands to sensitize the lanthanide-centered luminescence in both organic solutions and in the aqueous colloids. The applicability of the developed aqueous colloids as nanosensors will be demonstrated using their luminescent reply on ceftriaxone, which is the third generation of the cephalosporin antibiotic widely applied in treating such socially relevant bacterial infections as meningitis, pneumonia, and many others [44,45,46,47].

2. Experimental Section

Materials. All reagents were used as purchased from Sigma-Aldrich or Acros Chemicals without further purification. Solvents were purified using standard procedures before use. All reactions were run under an argon atmosphere unless in aqueous media. Ceftriaxone disodium salt from RUE Belmedpreparaty was used as purchased.
Syntheses. Ligand a was obtained using a procedure suggested by Magennis et al. [28], and ligand b was synthesized using a method described by Maass et al. [48]. Detailed synthetic procedures as well as their lanthanide complexes syntheses, [Ln(a)3] and [Ln(b)2(NO3)3], are given in SI. Synthetic protocols and characterization using 1H NMR, IR spectra, 31P NMR, and ESI-MS for ligands c and d are described in detail in ESI.
Nanoparticle synthesis. For each system, 0.5 mL of a solution of the corresponding complex (C = 3 mM) in acetonitrile was added dropwise with a syringe plunger into 2.5 mL of PSS (sodium polystyrene sulfonate) aqueous solution (1 g/L) containing NaCl (C = 0.5 M) while vigorously stirring (2200 rpm). The formation of fine white colloids was observed. To separate the colloid nanoparticles from acetonitrile, the mixtures were centrifuged, and the supernatant was removed and replaced with H2O (V = 3 mL). These operations were repeated twice. After each replacement of the solvent, the solutions were ultrasonicated for 10 min.
Methods. Mass spectra were recorded with an AmaZon X «Bruker» mass spectrometer. IR spectra were recorded with a Bruker Tensor-27 instrument for the samples in KBr pellets. NMR experiments were carried out with 400 MHz [400 MHz (1H), 162 MHz (31P)] or 600 MHz [600 MHz (1H), 243 MHz (31P),] spectrometers equipped with a pulsed gradient unit capable of producing magnetic field pulse gradients in the z-direction of 53.5 G cm–1. All spectra were acquired in a 5 mm gradient inverse broadband probe head. Chemical shifts (d) are expressed in parts per million, relative to the residual 1H signal of CDCl3, and the signals are designated as follows: s, singlet; d, doublet; t, triplet; m, multiplet. Coupling constants (J) are in hertz (Hz). Excitation and emission spectra and luminescence decay curves were registered with Fluorolog-QM (Horiba). The transmission electron microscopy (TEM) was performed using a Hitachi HT7700 (tungsten filament, HV = 100 kV). Samples were deposited on a 300-mesh copper grid with continuous carbon-formvar support film. XRD of crystals was performed with Bruker D8 QUEST. Detailed descriptions can be found in Electronic Supplementary Information (ESI). Powder X-ray diffraction (PXRD) measurements were performed with a Bruker D8 Advance diffractometer equipped with a Vario attachment and Vantec linear PSD, using Cu radiation (40 kV, 40 mA) monochromated with the curved Johansson monochromator (λ Cu Kα1 1.5406 Å). Electron absorption spectra were registered with Analytic Jena SPECORD 50plus, for dynamic light scattering and zeta-potential measurements Malvern Zetasizer Nano ZS was utilized. The fundamental basis of Judd–Ofelt analysis [49,50] and corresponding formulas [51,52] are collected in ESI.

3. Results and Discussion

3.1. Synthesis of Ligands c and d

Ligands a and b were obtained and reported previously [28,48]. Both syntheses were reproduced in this work in order to synthesize a row of lanthanide(III) complexes to conduct a comparative study. Ligands c and d were obtained using known methods with some adjustments as depicted in Figure 1. In brief, ligand c was synthesized via the interaction of 1-(dichloromethyl)-4-methoxybenzene and ethyl diphenylphosphinite, including Arbuzov rearrangement at high temperature neat until the reaction mixture solidified. The desired ((4-methoxyphenyl)methylene)bis(diphenylphosphine oxide) c was obtained individually with recrystallization as a white poorly-soluble solid. Ligand d was synthesized via the oxidation of a crude reaction mixture of corresponding phosphine obtained as described by Ogawa et al. [53]. The desired N-(diphenylphosphoryl)-N-(4-methoxyphenyl)-P,P-diphenylphosphinic amide c was obtained individually with two subsequent recrystallizations.

3.2. Synthesis of [Ln(L)x] Complexes, Ln = Eu3+, Tb3+, L = a, b, c, x = 1,2,3 and XRD Data

Lanthanide complexes of bis(phosphine oxide) (a) and 2-diphenylphosphineoxide-1-phenylethanone (b) were obtained previously and reproduced in this work in order to compare luminescent properties within the row of complexes [29,30]. X-ray crystal structures of [Tb(a)3] and [Eu(b)2(NO3)3] are illustrated in Figure 2a and 2b, respectively.
Single crystals of complex [Tb(c)(NO3)3(H2O)] as colorless prisms were prepared using slow evaporation of a THF solution. The compound crystallizes in the monoclinic space group C2/c as a crystallosolvate with 2.5 THF molecules per complex. One complex molecule is present in the asymmetric cell. Its molecular structure is shown in Figure 2c,d and reflects the 1:1 stoichiometry. Nine-coordinated Tb atom is surrounded by one ligand c attached by bis(phosphine oxide) chelation through the P=O coordination, three ditopic NO3- residues, and one water molecule. Interestingly, the [P=]O–Tb internuclear distances are notably different and equal to 2.368(1) and 2.295(1) Å. The internuclear distances between the Tb and coordinated oxygen atoms of NO3- vary between 2.430(2) and 2.507(1) Å. Deposition number CCDC 2,218,909 contains the supplementary crystallographic data for compound [Tb(c)(NO3)3(H2O)]. These data are provided free of charge by the joint Cambridge Crystallographic Data Centre and Fach informations zentrum Karlsruhe Access Structures service www.ccdc.cam.ac.uk/structures (Accessed on 10 November 2022).
X-ray structures of previously studied [Tb(a)3] and [Eu(b)2(NO3)3], as well as the newly obtained [Tb(c)(NO3)3(H2O)], are presented in Figure 2a–c to illustrate the difference in the inner-sphere environment of the lanthanide ions in the complexes. In particular, the unsaturated coordination environment of Tb3+ ion in [Tb(a)3] by six oxygen atoms derives from the chelation of three imido-bis-phosphinates. The coordination polyhedron of [Eu(b)2(NO3)3] is filled by ten oxygen atoms arising from the coordination of both ligands and nitrates, and the nine oxygen atoms in the polyhedra of complex [Tb(c)(NO3)3(H2O)] also arises from the coordination of one organic ligand, three nitrates, and one water molecule. Complex [Tb(a)3] crystallizes with two molecules in the asymmetric cell. Although both molecules are situated at the crystallographic 3-fold proper rotating axes, they show different coordination modes, namely, trigonal prismatic and octahedral. Complexes [Eu(b)2(NO3)3] and [Tb(c)(NO3)3(H2O)] are located in general position in the crystals and, consequently, they are asymmetric.
Thus, the structure of ligands is of great impact on the complex structure. It is worth noting the conversion of the ligand from phosphine oxide to phosphonate forms as the reason for the formation of complex [Tb(a)3] with the coordinative unsaturated inner-sphere environment of the Tb3+ ion. A similar structure is revealed for some 1,3-diketonate complexes of lanthanides [54,55]. In turn, the substitution of N–H by N–R in the structure of d (Figure 1) results in poor complexation. One can hypothesize that an impossibility of the deprotonation of ligand d explains its poor ability to form complex, while the ability of the phosphine oxide representative a with N–H bridging moiety to deprotonate prerequisites its high complexing ability. The ligands b and c tend to chelate without deprotonation, which agrees well with the literature data [30,31]. The smaller electron donating properties of both bis(phosphine oxide) c and ketophosphine oxide b vs. the anionic deprotonated form of ligand a result in the formation of the saturated coordination sphere due to the coordination of the nitrates and water molecule along with the organic ligands. The aforesaid difference in the coordination polyhedra can be of some impact on the lanthanide-centered luminescence of the complexes. It is also worth noting that the difference in the complex stoichiometry, which is 1:2 and 1:1 (metal-to-ligand ratio) for the ligands b and c, respectively, can be explained by the additional steric constraints arising from the introduction of the bulky methoxyphenyl moiety in the ligand c.

3.3. Absorption and Luminescent Properties of Ln(c)

Absorption spectra of the newly synthesized ligands c and d as well as their terbium complexes were recorded in CH3CN (Figure 3a). Both ligands are characterized by an absorption band at 230 nm responsible for the π→π* transition. The spectrum of [Tb(c)(NO3)3(H2O)] differs significantly from that of the ligand.
The as-synthesized terbium and europium complexes with ligands a, b, and c are well soluble in CH3CN. Their luminescence spectra recorded at the same instrumental conditions revealed that terbium centers are more effectively sensitized by ligands a and b vs. c (Figure 3b). It is worth assuming that the tris-chelation of ligand a can be a reason for better sheltering of a coordination center from solvent molecules, while the inner-sphere nitrates in [Tb(b)2(NO3)3] and [Tb(c)(NO3)3(H2O)] can easily be substituted by the solvent molecules. However, the excited state lifetime (τmeas) values calculated from the luminescence decay kinetic measurements (Table 1) remain high, arguing against dissociation of the complexes [Tb(b)2(NO3)3] and [Tb(c)(NO3)3(H2O)].
The sensitivity to changes in symmetry and strength of the ligand field is the peculiar feature of the Eu3+-centered luminescence. The intensity ratio of 5D0→7F2/5D0→7F1 transitions (R) is the well-known value that allows for following the changes in the symmetry and strength of the ligand field around Eu3+ ions. This derives from the fact that the intensity of the dipole transition 5D0→7F2 is hypersensitive to electric symmetry and strength of the ligand field around Eu3+ ions, while the magnetic dipole transition 5D0→7F1 is not affected by the surrounding charge distribution because it is parity-allowed, and its emission is often used as internal standard [56]. Thus, the R-values calculated using Equation (1) are collected in Table 1 along with the τ-values calculated from the luminescence decay kinetic measurements.
R = I ( D 5 0 → F 7 2 ) I ( D 5 0 → F 7 1 )
The higher the R, the lower the local symmetry around Eu3+ is with respect to an inversion center since a high local symmetry strongly reduces the electric dipolar emission without affecting the magnetic dipolar one, and vice versa. In addition, in many complexes, the ratio is high due to an increase in the covalency of Eu–ligand coordinative bonds, which lowers the symmetry.
Focusing our attention on Eu complexes, the PL emission spectra show a much different shape for the three analyzed complexes, as an indication of the different environment surrounding the rare earth ion. Indeed, the R-value is the highest for complex [Eu(a)3] as an indication of a low symmetry surrounding the rare earth ion. The opposite is observed for complexes [Eu(b)2(NO3)3] and [Eu(c)(NO3)3(H2O)], where the R-values barely exceed 1.0, thus, indicating that the magnetic transition intensity is similar to the electric dipolar one.
The luminescence decay kinetics of the europium complexes also demonstrate the mono-exponential decay, which argues for a rather poor dissociation of the complexes (Figure 4). The lifetime results (Table 1) are in agreement with the previous considerations. Due to the forbidden nature of the internal 4f transitions, the probability of electric dipole recombination is low, resulting in long lifetimes in the millisecond range as it occurs for [Eu(b)2(NO3)3] and [Eu(c)(NO3)3(H2O)] complexes. However, when the surrounding environment introduces an asymmetric perturbation to the wave functions, this increases the dipole transition rate and the electric dipole emission component, while it reduces the radiative lifetime. Thus, the calculated radiative lifetime reported in Table 1 is shorter for the complex [Eu(a)3] and longer for the other two. The measured lifetimes follow the same trend.

3.4. Synthesis of PSS-[Ln(L)x] Nanoparticles, L = a, b, c, x = 1,2, 3, Ln = Tb, Eu

Chasing applicability for biomedical purposes, the complexes were converted to water colloids according to the solvent change method [8], where the precipitated species are incorporated into the PSS capsules through an electrostatic attraction. Thus, the charge of the precipitated species is of great impact on the efficacy of the incorporation. The surface charge of the colloidal species can be measured by measuring their electrokinetic potential (ζ) values. Dropwise addition of the complexes in the acetonitrile solution (C = 1 mM) to water results in the formation of the colloids, which were characterized by measurements of their size and ζ-values (Table 2). These values were measured for the colloids formed from the Eu3+ complexes with the ligands (Table 2). The positive ζ-values of the colloids formed from complexes [Eu(b)2(NO3)3] and [Eu(c)(NO3)3(H2O)] are rather anticipated, since the surface exposed complex units can undergo partial degradation, most probably, due to the release of nitrate anions. The significant negative surface charging of the colloids from complex Eu(a)3 also argues for its partial degradation, while the significant basicity of the released deprotonated ligand triggers a formation of hydroxyls under the interaction with water molecules.
It is worth noting that the nanoprecipitation of the complexes in the solutions of PSS and NaCl results in the formation of the aqueous colloids, which are manifested by the average size values less than those of the nanoprecipitates formed in the aqueous solutions. The PSS-stabilized colloids exhibit high colloid stability, while their uncoated counterparts aggregate and precipitate within several hours. The efficient incorporation of the nanoprecipitates into the PSS-based aggregates is rather anticipated for the lanthanide complexes with ligands b and c since their nanoprecipitates are positively charged, while the incorporation of the negatively charged nanoprecipitates of complex [Eu(a)3] into the aggregates is rather unusual. However, we can keep in mind the high concentration of the counterions derived from the high concentration level of NaCl in the PSS solutions, which can facilitate the incorporation of the [Eu(a)3]-based nanoprecipitates into the PSS-capsules.
The efficacy of the complex transformation from the acetonitrile solutions into the PSS-stabilized colloids can be assessed by the partial leaching of the lanthanide ions. Thus, the equilibrium concentrations of the lanthanide ions were measured in the aqueous colloids and two first supernatants after the phase separation and the washing procedure (for more details see the experimental section). The percentage of the conversion calculated from the data is represented in Table 3 for the complexes [Eu(L)x]. The most efficient conversion is observed for [Eu(a)3], which indicates poor leaching of Eu3+ ions from the nanoprecipitates. The leaching is more pronounced for complexes [Eu(b)2(NO3)3] and [Eu(c)(NO3)3(H2O)], which correlates with the less tight binding of Eu3+ ions by ligands b and c than by ligand a. It is worth mentioning that ligands b and c tend to coordinate without deprotonation, while the tightest binding of Eu3+ by ligand a is due to its deprotonation, which enforces the coordination bonds in [Eu(a)3].
Figure 5a illustrates the morphology of PSS-[Eu(a)3] colloids dried on the formvar coated substrate. There are 35–70 nm particles of PSS stuffed by multiple 2–8 nm sized cores built of [Eu(a)3] complexes. Such plum-duff architecture is the key to more efficient sensing compared to PSS-PSS-[Eu(b)2(NO3)3] and [Eu(c)(NO3)3(H2O)] colloidal species (Figure S1) due to a highly developed surface. The produced colloids exhibit Eu3+-centered luminescence (Figure 5b). The R-values of the colloids follow a similar tendency as for the complexes in solutions (Table 1). Thus, the specific R-value of [Eu(a)3] in the acetonitrile solution and in the PSS-stabilized colloids argues for the similarity in the inner-sphere environment of the Eu3+ ion in both molecular and colloidal forms. The excited state lifetime values of the colloids (Table 1) also reveal the specificity of [Eu(a)3] similar to the complexes in the solutions. The aforesaid agrees well with the safe conversion of [Eu(a)3] complexes into colloids (Table 3).
The dried PSS-[Eu(a)3] colloids were analyzed using the PXRD method (Figure 5c,d). The PXRD pattern of the colloids reveals their crystalline nature with very poor if any contribution of an amorphous phase (Figure 5c,d). The PXRD pattern simulated out of single crystal data of [Eu(a)3] is also shown in Figure 5c for comparison with that of PSS-[Eu(a)3] colloids in order to prove their composition. The vast majority of reflections in diffractograms of [Eu(a)3] and PSS-[Eu(a)3] coincide. At the same time, comparative analysis of the difractograms of the powder samples of PSS-[Eu(a)3] colloids and ligand a represented in Figure 5d reveals no coincidence between the PXRD patterns of ligand a and PSS-[Eu(a)3]. This allows us to conclude that the nanoparticles contain a pure crystalline phase of the complex without an admixture of the separately precipitated ligand phase.

3.5. Detection of Ceftriaxone Using PSS-[Eu(a)3] Colloids

The high chemical stability of [Eu(a)3] and relative hydrophobicity ensured the efficient transformation of [Eu(a)3] into PSS-[Eu(a)3], which makes these colloids the most promising basis for reliable sensing of substrates. Short screening of antibiotics was performed for PSS-[Eu(a)3] water dispersions in terms of possible luminescent response. No quenching was observed for amoxicillin, while ciprofloxacin detection could be achieved only at high concentrations (Figure S2). In the meanwhile, the presence of micromolar amounts of ceftriaxone resulted in significant changes in emission intensity. The main europium band at 612 nm demonstrated quenching for the factor of 7.23 when 87.5 μM ceftriaxone was added (Figure 6a). Deviation of I0/I from the linear law in Stern–Volmer coordinates indicates a mixed, static, and dynamic mechanism of quenching, which is typical for dark complexes formation (Figure 6b) [57,58]. In turn, the dark complex formation observed for PSS-[Eu(a)3] colloids in the presence of ceftriaxone argues for the ligand exchange disturbing the ligand-to-metal energy transfer of [Eu(a)3]. The presence of the carboxylate and hydroxy group of 1,2,4-triazin-3-yl moiety in the structure of sodium ceftriaxone (Scheme S3, inset) prerequisites its efficiency in the ligand exchange. The limit of detection (LOD), calculated as 3σ/S (where σ is the standard deviation for blank experiments and S is the slope of the linear segment of luminescence intensity vs. the concentration of analyte), is equal to 0.974 μM, which is comparable to the previously reported values (Table 4). For comparative purposes, the luminescent response of PSS-[Eu(b)2(NO3)3] to ceftriaxone was also monitored (Figure S3). The latter colloids demonstrate a less sensitive response to the substrate, which can be explained by their mixed composition.
Commonly, a level of ceftriaxone is evaluated in blood serum or urine. For further use of the PSS-[Eu(a)3] nanoparticles for ceftriaxone detection in blood serum, the BSA, glutamic, and aspartic acids in 0.01 M phosphate buffer interfering effect was estimated. The luminescence response of PSS-[Eu(a)3] to ceftriaxone evaluated in the solutions modeling blood serum (Figure S4 in ESI) indicates that the applied concentration levels of the protein and amino acids provide an insignificant effect on the sensitivity of PSS-[Eu(a)3] to ceftriaxone. This argues for the applicability of PSS-[Eu(a)3] for bioanalytical purposes.

4. Conclusions

Summarizing, the present work demonstrates the three representatives of bis(phosphine oxides) and β-ketophosphine oxide as ligands for Tb3+ and Eu3+ ions. The nature of the bridging group between phosphine oxide moieties has a great impact on the complex structure. The specificity of the imido-group as the bridging one between two phosphoryl moieties phosphine oxide moieties, manifested by the possibility of conversion of imido- bis(phosphine oxides) to their phosphonate form, is the reason for the formation of complexes [Ln(a)3] (Ln = Eu3+, Tb3+) with the coordinative unsaturated inner-sphere environment of the Ln3+ ion. The β-ketophosphine oxide and bis(phosphine oxide) ligands with methylene bridging groups are efficiently coordinated to Ln3+ ions without deprotonation, while the complex ability is poor for the ligand possessing the N–R bridging group. The coordination of the ligands with the Ln3+ ions results in the efficient sensitization of both Tb3+- and Eu3+-centered luminescence. The ligand environment in the [Ln(a)3] complexes provides the specific ligand field symmetry, which is manifested by the specific spectral pattern and excited state lifetime value of [Eu(a)3]. Moreover, the high stability of the [Ln(a)3] complexes provides their safe conversion into PSS-[Ln(a)3] colloids, while the lanthanide complexes with carbamoylphosphine oxide and bis(phosphine oxide) ligands suffer from the partial degradation under the synthesis of the PSS-stabilized colloids. The red luminescence of PSS-[Eu(a)3] fitting to the wavelengths range of the so-called biological window exhibit the pronounced luminescent response on the antibiotic ceftriaxone, which allows for sensing the latter in aqueous solutions with the LOD value equal to 0.974 μM.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/nano13030438/s1: Figure S1. TEM image of PSS-[Eu(b)2(NO3)3] and PSS-[Eu(c)(NO3)3(H2O)]; Figure S2. Emission spectra of PSS-[Eu(a)3] colloids in the presence of increasing amounts of (a) amoxicillin and (b) ciprofloxacin in water; Figure S3. Gradual quenching of Eu3+ luminescence within the composition of PSS-[Eu(b)2(NO3)3] colloids in the presence of increasing amounts (0–3 equivalents) of ceftriaxone (C = 0.108 mM). Chemical structure of ceftriaxone is shown in the inset; Figure S4. Emission spectra of PSS-[Eu(a)3] colloids (C = 0.05 mM) in the presence of BSA (C = 1 g/L), glutamic (C = 175 µM), and aspartic (C = 30 µM) acids in 0.01 M phosphate buffer at the different concentrations of ceftriaxone disodium salt (0–55 µM). References [68,69,70,71] are cited in the supplementary materials.

Author Contributions

Conceptualization, R.Z., A.D. and A.M.; methodology, Y.Z. and Z.H.; software, A.T.G. and R.R.F.; validation, F.E., V.F.M. and A.M.; formal analysis, N.T. and G.N.; investigation, A.D., N.T., T.K. and T.S.; resources, F.E., Y.Z. and Z.H.; data curation, F.E., D.T., R.R.F. and A.T.G.; writing—original draft preparation, R.Z., A.D., A.M. and R.R.F.; writing—review and editing, A.M. and R.Z.; visualization, A.D., T.K. and R.R.F.; supervision, A.M. and R.Z.; project administration, V.F.M., A.M. and R.Z.; funding acquisition, R.Z., N.T., D.T. and T.S. All authors have read and agreed to the published version of the manuscript.

Funding

The authors thank the Russian Science Foundation (grant 22-23-00853) for financial support. The authors are grateful to the staff of the Distributed Spectral-Analytical Center of Shared Facilities for Study of Structure, Composition and Properties of Substances and Materials of Federal Research Center of Kazan Scientific Center of Russian Academy of Sciences» for their research and assistance in discussing the results.

Data Availability Statement

The data presented in this study are available in the article and electronic supplementary file.

Acknowledgments

Timur Abdullin is gratefully acknowledged for his valuable consultations. The authors acknowledge the Kazan Federal University Strategic Academic Leadership Program (PRIORITY-2030).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Comby, S.; Surender, E.M.; Kotova, O.; Truman, L.K.; Molloy, J.K.; Gunnlaugsson, T. Lanthanide-functionalized nanoparticles as MRI and luminescent probes for sensing and/or imaging applications. Inorg. Chem. 2014, 53, 1867–1879. [Google Scholar] [CrossRef]
  2. Zairov, R.; Mustafina, A.; Shamsutdinova, N.; Nizameev, I.; Moreira, B.; Sudakova, S.; Podyachev, S.; Fattakhova, A.; Safina, G.; Lundstrom, I.; et al. High performance magneto-fluorescent nanoparticles assembled from terbium and gadolinium 1,3-diketones. Sci. Rep. 2017, 7, 40846. [Google Scholar] [CrossRef] [Green Version]
  3. Bünzli, J.G.C.G. Lanthanide light for biology and medical diagnosis. J. Lumin. 2016, 170, 866–878. [Google Scholar] [CrossRef]
  4. Podyachev, S.N.; Sudakova, S.N.; Zairov, R.R.; Syakaev, V.V.; Masliy, A.N.; Dusek, M.; Gubaidullin, A.T.; Dovzhenko, A.P.; Buzyurova, D.N.; Lapaev, D.V.; et al. Modulating the Inclusive and Coordinating Ability of Thiacalix[4]arene and Its Antenna Effect on Yb3-Luminescence via Upper-Rim Substitution+. Molecules 2022, 27, 6793. [Google Scholar] [CrossRef]
  5. Metlin, M.T.; Ambrozevich, S.A.; Metlina, D.A.; Vitukhnovsky, A.G.; Taydakov, I.V. Luminescence of pyrazolic 1,3-diketone Pr3+ complex with 1,10-phenanthroline. J. Lumin. 2017, 188, 365–370. [Google Scholar] [CrossRef]
  6. Emelina, T.B.; Kalinovskaya, I.V.; Mirochnik, A.G. Europium(III) complex with powerful antenna ligands: Interligand interaction. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2019, 207, 222–228. [Google Scholar] [CrossRef]
  7. Metlin, M.T.; Goryachii, D.O.; Datskevich, N.P.; Asanov, R.K.; Aminev, D.F.; Metlina, D.A.; Taidakov, I.V. Photo- and Electroluminescent Properties of the Yb3+ Complex with Pyrazole-Substituted 1,3-Diketone and 1,10-Phenanthroline. Bull. Lebedev Phys. Inst. 2021, 48, 139–143. [Google Scholar] [CrossRef]
  8. Podyachev, S.N.; Zairov, R.R.; Mustafina, A.R. 1,3-Diketone Calix[4]arene Derivatives-A New Type of Versatile Ligands for Metal Complexes and Nanoparticles. Molecules 2021, 26, 1214. [Google Scholar] [CrossRef]
  9. Reid, B.L.; Stagni, S.; Malicka, J.M.; Cocchi, M.; Hanan, G.S.; Ogden, M.I.; Massi, M. Lanthanoid β-triketonates: A new class of highly efficient NIR emitters for bright NIR-OLEDs. Chem. Commun. 2014, 50, 11580–11582. [Google Scholar] [CrossRef] [Green Version]
  10. Mironov, L.Y.; Sveshnikova, E.B.; Ermolaev, V.L. Energy transfer from the singlet levels of diketones and dyes to lanthanide ions in nanoparticles consisting of their diketonate complexes. Opt. Spectrosc. 2014, 116, 933–940. [Google Scholar] [CrossRef]
  11. Clegg, J.K.; Li, F.; Lindoy, L.F. Oligo-β-diketones as versatile ligands for use in metallo-supramolecular chemistry: Recent progress and perspectives. Coord. Chem. Rev. 2022, 455, 214355. [Google Scholar] [CrossRef]
  12. Podyachev, S.N.; Gimazetdinova, G.S.; Sudakova, S.N.; Shamsutdinova, N.A.; Lapaev, D.V.; Syakaev, V.V.; Gubaidullin, A.T.; Nagimov, R.N.; Mustafina, A.R. Influence of upper rim dibromo-substitution in bis-1,3-diketone calix[4]arenes on spectral properties of ligands and their lanthanide complexes. Tetrahedron 2017, 73, 5397–5407. [Google Scholar] [CrossRef]
  13. Brites, C.D.S.; Lima, P.P.; Carlos, L.D. Tuning the sensitivity of Ln3+-based luminescent molecular thermometers through ligand design. J. Lumin. 2016, 169, 497–502. [Google Scholar] [CrossRef]
  14. Zairov, R.R.; Dovzhenko, A.P.; Podyachev, S.N.; Sudakova, S.N.; Kornev, T.A.; Shvedova, A.E.; Masliy, A.N.; Syakaev, V.V.; Alekseev, I.S.; Vatsouro, I.M.; et al. Role of PSS-based assemblies in stabilization of Eu and Sm luminescent complexes and their thermoresponsive luminescence. Colloids Surf. B Biointerfaces 2022, 217, 112664. [Google Scholar] [CrossRef]
  15. Pradhan, S.; Swain, N.; Prusty, S.; Sahu, R.K.; Mishra, S. Role of extractants and diluents in recovery of rare earths from waste materials. Mater. Today Proc. 2020, 30, 239–245. [Google Scholar] [CrossRef]
  16. Safiulina, A.; Borisova, N.; Grigoriev, M.; Baulin, D.; Baulin, V.; Tsivadze, A. Design of Extractants for F-Block Elements in a Series of (2-(Diphenylphosphoryl)methoxyphenyl)diphenylphosphine Oxide Derivatives: Synthesis, Quantum-Chemical, and Extraction Studies. Molecules 2021, 26, 2217. [Google Scholar] [CrossRef]
  17. Batchu, N.K.; Li, Z.; Verbelen, B.; Binnemans, K. Structural effects of neutral organophosphorus extractants on solvent extraction of rare-earth elements from aqueous and non-aqueous nitrate solutions. Sep. Purif. Technol. 2021, 255, 117711. [Google Scholar] [CrossRef]
  18. Kukkonen, E.; Virtanen, E.J.; Moilanen, J.O. α-Aminophosphonates, -Phosphinates, and -Phosphine Oxides as Extraction and Precipitation Agents for Rare Earth Metals, Thorium, and Uranium: A Review. Molecules 2022, 27, 3465. [Google Scholar] [CrossRef]
  19. Nazarova, A.; Padnya, P.; Cragg, P.J.; Stoikov, I. [1]Rotaxanes based on phosphorylated pillar[5]arenes. New J. Chem. 2022, 46, 2033–2037. [Google Scholar] [CrossRef]
  20. Nazarova, A.A.; Yakimova, L.S.; Padnya, P.L.; Evtugyn, V.G.; Osin, Y.N.; Cragg, P.J.; Stoikov, I.I. Monosubstituted pillar[5]arene functionalized with (amino)phosphonate fragments are “smart” building blocks for constructing nanosized structures with some s- and p-metal cations in the organic phase. New J. Chem. 2019, 43, 14450–14458. [Google Scholar] [CrossRef]
  21. Aslandukov, A.N.; Utochnikova, V.V.; Goriachiy, D.O.; Vashchenko, A.A.; Tsymbarenko, D.M.; Hoffmann, M.; Pietraszkiewicz, M.; Kuzmina, N.P. The development of a new approach toward lanthanide-based OLED fabrication: New host materials for Tb-based emitters. Dalt. Trans. 2018, 47, 16350–16357. [Google Scholar] [CrossRef]
  22. Platt, A.W.G. Lanthanide phosphine oxide complexes. Coord. Chem. Rev. 2017, 340, 62–78. [Google Scholar] [CrossRef]
  23. Casey, K.C.; Brown, A.M.; Robinson, J.R. Yttrium and lanthanum bis(phosphine-oxide)methanides: Structurally diverse, dynamic, and reactive. Inorg. Chem. Front. 2021, 8, 1539–1552. [Google Scholar] [CrossRef]
  24. Kariaka, N.; Litsis, O.; Kolomzarov, Y.; Gawryszewska, P.; Smola, S.; Rusakova, N.; Trush, V.; Sliva, T.; Amirkhanov, V. Luminescent thin films based on N-(diphenylphosphoryl)benzamide EuIII and TbIII complexes for light emitting diode technology. Chem. J. Mold. 2018, 13, 54–62. [Google Scholar] [CrossRef]
  25. Gerstel, M.; Koehne, I.; Reithmaier, J.P.; Pietschnig, R.; Benyoucef, M. Luminescent Properties of Phosphonate Ester-Supported Neodymium(III) Nitrate and Chloride Complexes. Molecules 2022, 28, 48. [Google Scholar] [CrossRef]
  26. Koehne, I.; Pietschnig, R. Synthesis of Geminal Bis- and Tetrakisphosphonate Ester Derivatives and Their Coordination Behavior Towards Ca(II) Ions. Eur. J. Inorg. Chem. 2022, 2022, e202200194. [Google Scholar] [CrossRef]
  27. Davis, D.; Carrod, A.J.; Guo, Z.; Kariuki, B.M.; Zhang, Y.-Z.; Pikramenou, Z. Imidodiphosphonate Ligands for Enhanced Sensitization and Shielding of Visible and Near-Infrared Lanthanides. Inorg. Chem. 2019, 58, 13268–13275. [Google Scholar] [CrossRef]
  28. Magennis, S.W.; Parsons, S.; Pikramenou, Z. Assembly of hydrophobic shells and shields around lanthanides. Chem.-A Eur. J. 2002, 8, 5761–5771. [Google Scholar] [CrossRef]
  29. Magennis, S.W.; Parsons, S.; Corval, A.; Woollins, J.D.; Pikramenou, Z. Imidodiphosphinate ligands as antenna units in luminescent lanthanide complexes. Chem. Commun. 1999, 61–62. [Google Scholar] [CrossRef]
  30. Leach, E.G.; Shady, J.R.; Boyden, A.C.; Emig, A.L.; Henry, A.T.; Connor, E.K.; Staples, R.J.; Schaertel, S.; Werner, E.J.; Biros, S.M. X-ray crystallographic, luminescence and NMR studies of phenacyldiphenylphosphine oxide with the Ln(iii) ions Sm, Eu, Gd, Tb and Dy. Dalt. Trans. 2017, 46, 15458–15469. [Google Scholar] [CrossRef]
  31. Lees, A.M.J.; Platt, A.W.G. Complexes of Lanthanide Nitrates with Bis(diphenylphosphino)methane Dioxide. Inorg. Chem. 2003, 42, 4673–4679. [Google Scholar] [CrossRef]
  32. Turanov, A.N.; Karandashev, V.K.; Artyushin, O.I.; Peregudov, A.S.; Khvostikov, V.A.; Bondarenko, N.A. Extraction Properties of Diphenyl{[N-(2-diphenylphosphinylethyl)-N-alkyl]carbamoylmethyl}phosphine Oxides in Nitric Acid Solutions. Russ. J. Inorg. Chem. 2020, 65, 905–913. [Google Scholar] [CrossRef]
  33. Turanov, A.N.; Karandashev, V.K.; Yarkevich, A.N. Novel Bis(diphenylcarbamoylmethylphosphine oxide) Ligand for Effective Extraction of Actinides and Lanthanides from Nitric Acid Solutions. Solvent Extr. Ion Exch. 2022, 40, 493–517. [Google Scholar] [CrossRef]
  34. Boehme, C.; Wipff, G. Carbamoylphosphine oxide complexes of trivalent lanthanide cations: Role of counterions, ligand binding mode, and protonation investigated by quantum mechanical calculations. Inorg. Chem. 2002, 41, 727–737. [Google Scholar] [CrossRef]
  35. Bryleva, Y.A.; Artem’ev, A.V.; Glinskaya, L.A.; Rakhmanova, M.I.; Samsonenko, D.G.; Komarov, V.Y.; Rogovoy, M.I.; Davydova, M.P. Bright photo- and triboluminescence of centrosymmetric Eu(iii) and Tb(iii) complexes with phosphine oxides containing azaheterocycles. New J. Chem. 2021, 45, 13869–13876. [Google Scholar] [CrossRef]
  36. Xu, H.; Yin, K.; Huang, W. Synthesis, photophysical and electroluminescent properties of a novel bright light-emitting Eu3+ complex based on a fluorene-containing bidentate aryl phosphine oxide. Synth. Met. 2010, 160, 2197–2202. [Google Scholar] [CrossRef]
  37. Davydov, N.; Zairov, R.; Mustafina, A.; Syakayev, V.; Tatarinov, D.; Mironov, V.; Eremin, S.; Konovalov, A.; Mustafin, M. Determination of fluoroquinolone antibiotics through the fluorescent response of Eu(III) based nanoparticles fabricated by layer-by-layer technique. Anal. Chim. Acta 2013, 784, 65–71. [Google Scholar] [CrossRef]
  38. Shamsutdinova, N.; Zairov, R.; Mustafina, A.; Podyachev, S.; Sudakova, S.; Nizameev, I.; Kadirov, M.; Amirov, R. Interfacial interactions of hard polyelectrolyte-stabilized luminescent colloids with substrates. Colloids Surf. A Physicochem. Eng. Asp. 2015, 482, 231–240. [Google Scholar] [CrossRef]
  39. Makedonskaya, M.I.; Veselova, I.A.; Kalmykov, S.N.; Shekhovtsova, T.N. Novel biosensing system for the simultaneous multiplex fluorescent determination of catecholamines and their metabolites in biological liquids. J. Pharm. Biomed. Anal. 2018, 156, 133–141. [Google Scholar] [CrossRef]
  40. Wang, X.; Chang, H.; Xie, J.; Zhao, B.; Liu, B.; Xu, S.; Pei, W.; Ren, N.; Huang, L.; Huang, W. Recent developments in lanthanide-based luminescent probes. Coord. Chem. Rev. 2014, 273–274, 201–212. [Google Scholar] [CrossRef]
  41. Rahbar, N.; Abbaszadegan, P.; Savarizadeh, A. A sensitive fluorescent sensing strategy for nanomolar levels of metformin using graphitic carbon nitride nanosheets as nanofluoroprobe. Anal. Chim. Acta 2018, 1026, 117–124. [Google Scholar] [CrossRef] [PubMed]
  42. Zairov, R.R.; Dovzhenko, A.P.; Podyachev, S.N.; Sudakova, S.N.; Masliy, A.N.; Syakaev, V.V.; Gimazetdinova, G.S.; Nizameev, I.R.; Lapaev, D.V.; Budnikova, Y.H.; et al. Rational design of efficient nanosensor for glyphosate and temperature out of terbium complexes with 1,3-diketone calix[4]arenes. Sens. Actuators B Chem. 2022, 350, 130845. [Google Scholar] [CrossRef]
  43. Zairov, R.R.; Nagimov, R.N.; Sudakova, S.N.; Lapaev, D.V.; Syakaev, V.V.; Gimazetdinova, G.S.; Voloshina, A.D.; Shykula, M.; Nizameev, I.R.; Samigullina, A.I.; et al. Polystyrenesulfonate-coated nanoparticles with low cytotoxicity for determination of copper(II) via the luminescence of Tb(III) complexes with new calix[4]arene derivatives. Microchim. Acta 2018, 185, 4–13. [Google Scholar] [CrossRef]
  44. Marais, O. Le traitement par ceftriaxone des méningites bactériennes chez l’enfant est efficace. Option/Bio 2011, 22, 4. [Google Scholar] [CrossRef]
  45. Tiltnes, T.S.; Kehrer, M.; Hughes, H.; Morris, T.E.; Justesen, U.S. Ceftriaxone treatment of spondylodiscitis and other serious infections with Cutibacterium acnes. J. Antimicrob. Chemother. 2020, 75, 3046–3048. [Google Scholar] [CrossRef]
  46. Han, Y.; Yin, Y.; Dai, X.; Chen, S.; Yang, L.; Zhu, B.; Zhong, N.; Cao, W.; Zhang, X.; Wu, Z.; et al. Widespread Use of High-dose Ceftriaxone Therapy for Uncomplicated Gonorrhea Without Reported Ceftriaxone Treatment Failure: Results From 5 Years of Multicenter Surveillance Data in China. Clin. Infect. Dis. 2020, 70, 99–105. [Google Scholar] [CrossRef]
  47. File, T.M.; Eckburg, P.B.; Talbot, G.H.; Llorens, L.; Friedland, H.D. Macrolide therapy for community-acquired pneumonia due to atypical pathogens: Outcome assessment at an early time point. Int. J. Antimicrob. Agents 2017, 50, 247–251. [Google Scholar] [CrossRef]
  48. Maass, J.S.; Wilharm, R.K.; Luck, R.L.; Zeller, M. Photoluminescent properties of three lanthanide compounds of formulae LnCl3(diphenyl((5-phenyl-1H-pyrazol-3-yl)methyl)phosphine oxide)2, Ln = Sm, Eu and Tb: X-ray structural, emission and vibrational spectroscopies, DFT and thermogravimetric studies. Inorganica Chim. Acta 2018, 471, 481–492. [Google Scholar] [CrossRef]
  49. Judd, B.R. Optical absorption intensities of rare-earth ions. Phys. Rev. 1962, 127, 750–761. [Google Scholar] [CrossRef]
  50. Ofelt, G.S. Intensities of crystal spectra of rare-earth ions. J. Chem. Phys. 1962, 37, 511–519. [Google Scholar] [CrossRef]
  51. Malba, C.; Sudhakaran, U.P.; Borsacchi, S.; Geppi, M.; Enrichi, F.; Natile, M.M.; Armelao, L.; Finotto, T.; Marin, R.; Riello, P.; et al. Structural and photophysical properties of rare-earth complexes encapsulated into surface modified mesoporous silica nanoparticles. Dalt. Trans. 2014, 43, 16183–16196. [Google Scholar] [CrossRef] [PubMed]
  52. Werts, M.H.V.; Jukes, R.T.F.; Verhoeven, J.W. The emission spectrum and the radiative lifetime of Eu3+ in luminescent lanthanide complexes. Phys. Chem. Chem. Phys. 2002, 4, 1542–1548. [Google Scholar] [CrossRef]
  53. Ogawa, T.; Kajita, Y.; Wasada-Tsutsui, Y.; Wasada, H.; Masuda, H. Preparation, Characterization, and Reactivity of Dinitrogen Molybdenum Complexes with Bis(diphenylphosphino)amine Derivative Ligands that Form a Unique 4-Membered P–N–P Chelate Ring. Inorg. Chem. 2013, 52, 182–195. [Google Scholar] [CrossRef] [PubMed]
  54. Stabnikov, P.A.; Pervukhina, N.V.; Kuratieva, N.V.; Kryuchkova, N.A.; Korolkov, I.V.; Urkasym kyzy, S.; Sysoev, S.V.; Babailov, S.P. New polymorphic modification of Y, Ho, Tm and Lu tris-2,2,6,6-tetramethyl-heptane-2,4-dionates: Structure, volatility and luminescence. Polyhedron 2021, 198, 115077. [Google Scholar] [CrossRef]
  55. Huang, S.; Sysoev, S.V.; Stabnikov, P.A.; Pervukhina, N.V.; Korolkov, I.V.; Mosyagina, S.A. Crystal structures of tris-dipivaloylmetanates of Tm3+ and Yb3+. Jiegou Huaxue 2018, 37, 640–644. [Google Scholar] [CrossRef]
  56. Levy, D.; Reisfeld, R.; Avnir, D. Fluorescence of europium(III) trapped in silica gel-glass as a probe for cation binding and for changes in cage symmetry during gel dehydration. Chem. Phys. Lett. 1984, 109, 593–597. [Google Scholar] [CrossRef]
  57. Bünzli, J.-C.G.C.G. On the design of highly luminescent lanthanide complexes. Coord. Chem. Rev. 2015, 293–294, 19–47. [Google Scholar] [CrossRef]
  58. Rusakova, N.V.; Kost, S.S.; Mustafina, A.R.; Amirov, R.R.; Zairov, R.R.; Solovieva, S.E.; Antipin, I.S.; Konovalov, A.I.; Korovin, Y.V. Spectral-luminescence and magnetic relaxation properties of lanthanide-p-sulfonatothiacalix[4]arenes in aqueous solution of surfactants. Russ. Chem. Bull. 2008, 57, 567–572. [Google Scholar] [CrossRef]
  59. Karpov, V.M.; Spektor, D.V.; Beklemishev, M.K. Determination of ceftriaxone by the fluorescence quenching of quantum dots using binding with polyethyleneimine. J. Anal. Chem. 2016, 71, 519–526. [Google Scholar] [CrossRef]
  60. Shah, J.; Jan, M.R.; Shah, S.; Naeem, M. Spectrofluorimetric Protocol for Ceftriaxone in Commercial Formulation and Human Plasma After Condensation with Formaldehyde and Ethyl Acetoacetate. J. Fluoresc. 2011, 21, 2155–2163. [Google Scholar] [CrossRef] [PubMed]
  61. Zhang, D.; Ma, Y.; Zhou, M.; Li, L.; Chen, H. Determination of ceftriaxone sodium in pharmaceutical formulations by flow injection analysis with acid potassium permanganate chemiluminescence detection. Anal. Sci. 2006, 22, 183–186. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  62. Shah, J.; Jan, M.R.; Shah, S. Inayatullah Development and validation of a spectrofluorimetric method for the quantification of ceftriaxone in pharmaceutical formulations and plasma. Luminescence 2013, 28, 516–522. [Google Scholar] [CrossRef] [PubMed]
  63. Pourmahdi, N.; Sarrafi, A.H.M.; Larki, A. Carbon Dots Green Synthesis for Ultra-Trace Determination of Ceftriaxone Using Response Surface Methodology. J. Fluoresc. 2019, 29, 887–897. [Google Scholar] [CrossRef]
  64. Narimani, S.; Samadi, N. Rapid trace analysis of ceftriaxone using new fluorescent carbon dots as a highly sensitive turn-off nanoprobe. Microchem. J. 2021, 168, 106372. [Google Scholar] [CrossRef]
  65. Chullasat, K.; Kanatharana, P.; Bunkoed, O. Nanocomposite optosensor of dual quantum dot fluorescence probes for simultaneous detection of cephalexin and ceftriaxone. Sens. Actuators B Chem. 2019, 281, 689–697. [Google Scholar] [CrossRef]
  66. Samadi, N.; Narimani, S. An ultrasensitive and selective method for the determination of Ceftriaxone using cysteine capped cadmium sulfide fluorescence quenched quantum dots as fluorescence probes. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 2016, 163, 8–12. [Google Scholar] [CrossRef] [PubMed]
  67. Qu, J.; Zhu, Z.; Bai, X.; Qu, J. Determination of Ceftriaxone Sodium by Fluorescence Probes of L-Cysteine Capped ZnS Quantum Dots. Nanosci. Nanotechnol. Lett. 2013, 5, 1051–1057. [Google Scholar] [CrossRef]
  68. Gonzalez, M.A.; Walker, A.S.; Cao, K.J.; Lazzari-Dean, J.R.; Settineri, N.S.; Kong, E.J.; Kramer, R.H.; Miller, E.W. Voltage Imaging with a NIR-Absorbing Phosphine Oxide Rhodamine Voltage Reporter. J. Am. Chem. Soc. 2021, 143, 2304–2314. [Google Scholar] [CrossRef] [PubMed]
  69. Reisfeld, R.; Zigansky, E.; Gaft, M. Europium probe for estimation of site symmetry in glass films, glasses and crystals. Mol. Phys. 2004, 102, 1319–1330. [Google Scholar] [CrossRef]
  70. Sheldrick, G.M. SHELXT—Integrated space-group and crystal-structure determination. Acta Crystallogr. Sect. A Found. Adv. 2015, 71, 3–8. [Google Scholar] [CrossRef]
  71. Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Nanomaterials 13 00438 g001 550
Figure 1. Ligands synthesized for this study: N-(diphenylphosphoryl)-P,P-diphenylphosphinicamide (a), 2-(diphenylphosphoryl)-1-phenylethan-1-one (b), ((4-methoxyphenyl)methylene)bis(diphenylphosphine oxide) (c), N-(diphenylphosphoryl)-N-(4-methoxyphenyl)-P,P-diphenylphosphinic amide (d). Synthetic routes employed in this work to synthesize new ligands c and d with p-methoxyphenyl substituent at α-position.
Figure 1. Ligands synthesized for this study: N-(diphenylphosphoryl)-P,P-diphenylphosphinicamide (a), 2-(diphenylphosphoryl)-1-phenylethan-1-one (b), ((4-methoxyphenyl)methylene)bis(diphenylphosphine oxide) (c), N-(diphenylphosphoryl)-N-(4-methoxyphenyl)-P,P-diphenylphosphinic amide (d). Synthetic routes employed in this work to synthesize new ligands c and d with p-methoxyphenyl substituent at α-position.
Nanomaterials 13 00438 g001
Nanomaterials 13 00438 g002 550
Figure 2. Comparison of the X-ray structures of complexes [Tb(a)3] (a), [Eu(b)2(NO3)3] (b), and [Tb(c)(NO3)3(H2O)] (c). Metal atoms are shown as polyhedra. Hydrogen atoms are omitted for clarity. In the case of [Tb(a)3], both molecules represented in the asymmetric cell are shown. ORTEP of complex [Tb(c)(NO3)3(H2O)] (d) at the 50% probability level for non-hydrogen atoms according to single-crystal X-ray diffraction. THF solvent molecules are omitted for clarity. Selected internuclear distances [Å]: Tb1–O1 2.368(1), Tb1–O2 2.295(1), Tb1–O1w 2.353(2), Tb1–O11 2.430(2), Tb1–O12 2.507(1), Tb1–O21 2.498(1), Tb1–O22 2.487(1), Tb1–O31 2.465(2), Tb1–O32 2.435(2), P1–O1 1.505(1), P2–O2 1.500(1).
Figure 2. Comparison of the X-ray structures of complexes [Tb(a)3] (a), [Eu(b)2(NO3)3] (b), and [Tb(c)(NO3)3(H2O)] (c). Metal atoms are shown as polyhedra. Hydrogen atoms are omitted for clarity. In the case of [Tb(a)3], both molecules represented in the asymmetric cell are shown. ORTEP of complex [Tb(c)(NO3)3(H2O)] (d) at the 50% probability level for non-hydrogen atoms according to single-crystal X-ray diffraction. THF solvent molecules are omitted for clarity. Selected internuclear distances [Å]: Tb1–O1 2.368(1), Tb1–O2 2.295(1), Tb1–O1w 2.353(2), Tb1–O11 2.430(2), Tb1–O12 2.507(1), Tb1–O21 2.498(1), Tb1–O22 2.487(1), Tb1–O31 2.465(2), Tb1–O32 2.435(2), P1–O1 1.505(1), P2–O2 1.500(1).
Nanomaterials 13 00438 g002
Nanomaterials 13 00438 g003 550
Figure 3. (a) UV-Vis absorption spectra of ligand c (1), c in the presence of triethylamine (2) and c in the presence of triethylamine and an equimolar amount of terbium(III) (C = 10–5 M). Excitation and emission spectra of [Ln(a)3] (1), [Ln(b)2(NO3)3] (2), [Ln(c)(NO3)3(H2O)] (3), (Ln = Tb3+ (b); Ln = Eu3+ (c)) (CLn = 10–5 M).
Figure 3. (a) UV-Vis absorption spectra of ligand c (1), c in the presence of triethylamine (2) and c in the presence of triethylamine and an equimolar amount of terbium(III) (C = 10–5 M). Excitation and emission spectra of [Ln(a)3] (1), [Ln(b)2(NO3)3] (2), [Ln(c)(NO3)3(H2O)] (3), (Ln = Tb3+ (b); Ln = Eu3+ (c)) (CLn = 10–5 M).
Nanomaterials 13 00438 g003
Nanomaterials 13 00438 g004 550
Figure 4. Luminescence decay curves for [Eu(L)x] (a) and PSS-[Eu(L)x], (b) in logarithmic scale (L = a(1), b(2), c(3)) under the excitation of corresponding wavelengths (Table 1).
Figure 4. Luminescence decay curves for [Eu(L)x] (a) and PSS-[Eu(L)x], (b) in logarithmic scale (L = a(1), b(2), c(3)) under the excitation of corresponding wavelengths (Table 1).
Nanomaterials 13 00438 g004
Nanomaterials 13 00438 g005 550
Figure 5. (a) TEM image of PSS-[Eu(a)3]. (b) Excitation and emission spectra of PSS-[Eu(L)x] (L = a, b, c, x = 3,2,1, respectively). (c) Simulated PXRD pattern out of single crystal data of [Eu(a)3] (2) in comparison to dried PSS-[Eu(a)3] PXRD pattern (1). (d) PXRD patterns of dried PSS-[Eu(a)3] (1) and ligand a (2).
Figure 5. (a) TEM image of PSS-[Eu(a)3]. (b) Excitation and emission spectra of PSS-[Eu(L)x] (L = a, b, c, x = 3,2,1, respectively). (c) Simulated PXRD pattern out of single crystal data of [Eu(a)3] (2) in comparison to dried PSS-[Eu(a)3] PXRD pattern (1). (d) PXRD patterns of dried PSS-[Eu(a)3] (1) and ligand a (2).
Nanomaterials 13 00438 g005
Nanomaterials 13 00438 g006 550
Figure 6. (a) Gradual quenching of Eu3+ luminescence within the composition of PSS-[Eu(a)3] colloids in the presence of increasing amounts of ceftriaxone (C = 57.4 μM). (b) I/I0 values vs. concentration of ceftriaxone, I0 and I are the luminescence intensities of PSS-[Eu(a)3] colloids without and in the presence of a certain concentration of ceftriaxone, respectively (1). Tangent for the curve (1) in the low-concentration region used for LOD calculation.
Figure 6. (a) Gradual quenching of Eu3+ luminescence within the composition of PSS-[Eu(a)3] colloids in the presence of increasing amounts of ceftriaxone (C = 57.4 μM). (b) I/I0 values vs. concentration of ceftriaxone, I0 and I are the luminescence intensities of PSS-[Eu(a)3] colloids without and in the presence of a certain concentration of ceftriaxone, respectively (1). Tangent for the curve (1) in the low-concentration region used for LOD calculation.
Nanomaterials 13 00438 g006
Table
Table 1. Decay parameters and excitation wavelengths (λexc) for [Eu(L)x] in CH3CN.
Table 1. Decay parameters and excitation wavelengths (λexc) for [Eu(L)x] in CH3CN.
RTau_Rad (ms)lexc (nm)Tau_Meas(ms)PL Efficiency
[Tb(a)3]-- 2.20
[Tb(b)2(NO3)3]-- 4.79
[Tb(c)(NO3)3(H2O)]-- 3.05
[Eu(a)3]11.221.492751.51.00
[Eu(b)2(NO3)3]1.526.862713.900.57
[Eu(c)(NO3)3(H2O)]1.387.402714.200.57
PSS-[Eu(a)3]12.181.412730.460.33
PSS-[Eu(b)2(NO3)3]1.178.102713.500.43
PSS[Eu(c)(NO3)3(H2O)]0.8610.132713.330.33
Table
Table 2. DLS data (hydrodynamic diameter (dh), polydispersity index (PDI), and electrokinetic potential (ζ)) for [Eu(L)x] precipitates and PSS-[Ln(L)x] colloids in water.
Table 2. DLS data (hydrodynamic diameter (dh), polydispersity index (PDI), and electrokinetic potential (ζ)) for [Eu(L)x] precipitates and PSS-[Ln(L)x] colloids in water.
Namedh
(nm)		PDIζ
(mV)
[Eu(a)3]1305.0 ± 62.70.199 ± 0.182–32.9 ± 0.6
[Eu(b)2(NO3)3]878.6 ± 28.90.659 ± 0.01635.7 ± 0.5
[Eu(c)(NO3)3(H2O)]1922.0 ± 133.50.265 ± 0.157 28.3 ± 1.2
PSS-[Eu(a)3]314.9 ± 11.20.272 ± 0.006–27.1 ± 0.7
PSS-[Eu(b)2(NO3)3]522.2 ± 58.30.549 ± 0.040–67.1 ± 0.8
PSS-[Eu(c)(NO3)3(H2O)]646.9 ± 68.50.561 ± 0.038–62.0 ± 2.3
Table
Table 3. The equilibrium Eu3+ concentrations in the aqueous colloids and the supernatants after the phase separation and the washing procedure along with the percentage of Eu3+ in the colloids and supernatants.
Table 3. The equilibrium Eu3+ concentrations in the aqueous colloids and the supernatants after the phase separation and the washing procedure along with the percentage of Eu3+ in the colloids and supernatants.
IntroducedRemain within the Composition of ColloidsCLn in Supernatant 1CLn in Supernatant 2Total Loss of Ln(III)
мMмM%мM%мM%мM%
PSS-[Eu(a)3]0.50.34468.940.1326.500.0234.550.15531.05
PSS-[Eu(b)2(NO3)3]0.50.10821.690.3773.490.0244.820.39278.31
PSS-[Eu(c)(NO3)3(H2O)]0.50.11623.290.3837.670.0071.3838.3676.71
Table
Table 4. LOD values of ceftriaxone detection for various luminescent nanomaterials/compounds reported in the literature.
Table 4. LOD values of ceftriaxone detection for various luminescent nanomaterials/compounds reported in the literature.
Luminescent CompoundLOD (M)
CdSe/CdS/ZnS quantum dots [59]1 × 10–6
Ceftriaxone converted into a fluorescent compound [60]3.5  ×  10−8
Chemiluminescence emission generated from the oxidation of ceftriaxone sodium [61]4.5 × 10–8
Ceftriaxone converted into a fluorescent product [62]2.3 × 10–9
Carbonized blue crab shell carbon dots [63]9.0 × 10–9
Chicken drumstick-derived carbon dots [64]4.4 ×10–10
Graphene quantum dots in a molecularly imprinted polymer MIP-GQDs [65]1.8 × 10–10
L-cysteine (Cys) coated CdS QDs [66]1.3 × 10–9
L-cysteine capped ZnS (L-Cys-ZnS) QDs [67]9.0 × 10−8
Our paper9.7 × 10–7
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zairov, R.; Dovzhenko, A.; Terekhova, N.; Kornev, T.; Zhou, Y.; Huang, Z.; Tatarinov, D.; Nizameeva, G.; Fayzullin, R.R.; Gubaidullin, A.T.; et al. Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection. Nanomaterials 2023, 13, 438. https://doi.org/10.3390/nano13030438

AMA Style

Zairov R, Dovzhenko A, Terekhova N, Kornev T, Zhou Y, Huang Z, Tatarinov D, Nizameeva G, Fayzullin RR, Gubaidullin AT, et al. Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection. Nanomaterials. 2023; 13(3):438. https://doi.org/10.3390/nano13030438

Chicago/Turabian Style

Zairov, Rustem, Alexey Dovzhenko, Natalia Terekhova, Timur Kornev, Ying Zhou, Zeai Huang, Dmitry Tatarinov, Guliya Nizameeva, Robert R. Fayzullin, Aidar T. Gubaidullin, and et al. 2023. "Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection" Nanomaterials 13, no. 3: 438. https://doi.org/10.3390/nano13030438

APA Style

Zairov, R., Dovzhenko, A., Terekhova, N., Kornev, T., Zhou, Y., Huang, Z., Tatarinov, D., Nizameeva, G., Fayzullin, R. R., Gubaidullin, A. T., Salikhova, T., Enrichi, F., Mironov, V. F., & Mustafina, A. (2023). Phosphineoxide-Chelated Europium(III) Nanoparticles for Ceftriaxone Detection. Nanomaterials, 13(3), 438. https://doi.org/10.3390/nano13030438

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop